The deal size was reduced to $125M in common stock from $150M in common stock. Goldman Sachs and JPMorgan acted as joint book running managers for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BLUE:
- Bluebird Bio announces $150M common stock offering
- Short Report: Rebound in Guess and GroupOn shares driving short-covering
- Bluebird Bio price target lowered by $3 at Wells Fargo, here’s why
- Bluebird Bio price target lowered to $5 from $8 at Wells Fargo
- Bluebird in deal with group representing 100M covered lives, after FDA approval
